Li Xiyan について
National Institute for Viral Disease Control and Prevention,Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases,Chinese Center for Disease Control and Prevention ; Key Laboratory for Medical Virology, National Health and Family Planning Commission について
Zhao Xiang について
National Institute for Viral Disease Control and Prevention,Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases,Chinese Center for Disease Control and Prevention ; Key Laboratory for Medical Virology, National Health and Family Planning Commission について
Tan Minju について
National Institute for Viral Disease Control and Prevention,Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases,Chinese Center for Disease Control and Prevention ; Key Laboratory for Medical Virology, National Health and Family Planning Commission について
National Institute for Viral Disease Control and Prevention,Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases,Chinese Center for Disease Control and Prevention ; Key Laboratory for Medical Virology, National Health and Family Planning Commission について
Cheng Yanhui について
National Institute for Viral Disease Control and Prevention,Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases,Chinese Center for Disease Control and Prevention ; Key Laboratory for Medical Virology, National Health and Family Planning Commission について
Huang Weijuan について
National Institute for Viral Disease Control and Prevention,Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases,Chinese Center for Disease Control and Prevention ; Key Laboratory for Medical Virology, National Health and Family Planning Commission について
Wang Dayan について
National Institute for Viral Disease Control and Prevention,Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases,Chinese Center for Disease Control and Prevention ; Key Laboratory for Medical Virology, National Health and Family Planning Commission について
Shu Yuelong について
National Institute for Viral Disease Control and Prevention,Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases,Chinese Center for Disease Control and Prevention ; Key Laboratory for Medical Virology, National Health and Family Planning Commission について
Zhonghua Shiyan he Linchuang Bingduxue Zazhi について
最適化 について
ウイルス について
インフルエンザウイルス について
PCR法 について
変異 について
ワクチン株 について
PCRプライマー について
ゲノム配列 について
季節性 について
Influenza virus について
H3N2 Subtype について
Sequencing について
Whole genome について
遺伝子の構造と化学 について
植物の生化学 について
Sanger法 について
季節性 について
亜型 について
インフルエンザウイルス について
ゲノム配列 について